Company Filing History:
Years Active: 2003-2005
Title: Ross Binder: Innovator in Biochemical Engineering
Introduction
Ross Binder is a notable inventor based in Manlius, NY (US). He has made significant contributions to the field of biochemical engineering, particularly in the development of enzymes that have practical applications in pharmaceuticals. With a total of 2 patents, Binder's work is recognized for its innovative approach to enzyme production.
Latest Patents
One of Ross Binder's latest patents is for the glutaryl cephalosporin amidase derived from Pseudomonas diminuta strain BS-203. This invention provides a glutaryl 7-ACA amidase that catalyzes the hydrolysis of 7-β-(4-carboxybutanamido)-cephalosporanic acid into 7-aminocephalosporanic acid and glutaric acid. The patent also includes nucleic acid sequences, vectors, and host cells that are useful in the production of this amidase. The glutaryl 7-ACA amidase has potential applications in the preparation of 7-aminocephalosporanic acid, which is important in antibiotic synthesis.
Career Highlights
Ross Binder is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work at this leading pharmaceutical company allows him to collaborate with other experts in the field and contribute to innovative solutions in drug development.
Collaborations
Throughout his career, Binder has worked alongside talented colleagues, including Joanne L. Brown and Thomas J. Franceschini. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
In summary, Ross Binder is a distinguished inventor whose work in biochemical engineering has led to valuable patents and contributions to the pharmaceutical industry. His innovative research continues to impact the development of important medical treatments.